Kotak Flexi Cap Fund Direct Growth NAV Rises to ₹98.13 on 6 November 2026; 3-Year CAGR at 13.13%

Key Takeaways

• Kotak Flexi Cap Fund Direct Growth recorded an exact NAV of ₹98.13 on 6 November 2026, rising 0.91% over the previous valuation point.
• Kotak Mutual Fund's latest performance snapshot showed a 3-year CAGR of 13.13%, a 5-year annualised return of 10.92% and a 1-year return of 1.16%.
• The AMC reported assets under management of approximately ₹52,614 crore as of 31 October 2026, with an expense ratio of 0.62% in its latest key-ratio disclosure.
• The latest portfolio mix was predominantly large-cap, with 71.03% in large-cap stocks, 24.35% in mid caps, 3.14% in small caps and 1.48% in debt and money-market instruments.

Kotak Flexi Cap Fund Direct Growth recorded a NAV of ₹98.13 on 6 November 2026, representing a 0.91% increase over the previous valuation point. The exact-date NAV was cross-checked separately, while the Kotak Mutual Fund page supplied for this article continues to display ₹98.13 as the scheme's current Direct Growth NAV.

Kotak AMC's latest historical-return disclosure showed the Direct Growth plan delivering a 1-year return of 1.16%, a 3-year CAGR of 13.13% and a 5-year annualised return of 10.92%. Its return since inception was displayed at 15.46%. These are historical performance figures and should be read separately from the one-day NAV movement.

The scheme managed approximately ₹52,614 crore as of 31 October 2026, while average assets under management stood at ₹52,438 crore. Kotak's key-ratio section showed an expense ratio of 0.62%, standard deviation of 15.34%, beta of 0.95 and Sharpe ratio of 0.33. The minimum initial investment was ₹100, with additional investments also starting at ₹100.

Portfolio positioning remained tilted towards larger companies. The AMC's 31 October portfolio snapshot showed 71.03% in large caps, 24.35% in mid caps and 3.14% in small caps, alongside 1.48% in debt and money-market instruments. Banks formed the largest sector allocation at 23.02%, followed by retailing at 6.77%, chemicals and petrochemicals at 6.74% and pharmaceuticals and biotechnology at 6.57%.

The scheme is a flexi-cap fund, meaning its mandate allows allocation across large-, mid- and small-cap companies without fixed market-cap proportions. The ₹98.13 NAV represents the verified unit value for 6 November 2026 and does not imply future performance.

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.